Leerink Partners Sticks to Its Buy Rating for AnaptysBio (ANAB)
In a report released on April 1, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...
Business Insider12d
Anaptys Announces Stock Repurchase Plan
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its ...
kalkinemedia15d
How Does AnaptysBio (NASDAQ:ANAB) Fit Into the Broader Biotech Landscape?
Highlights,AlphaQuest LLC significantly increased its equity activity related to AnaptysBio in the recent quarter.,Other organizations, including Victory Capital Management, made notable portfolio ...
Yahoo Finance17d
AnaptysBio Inc (AN6.MU)
Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...
Benzinga.com23d
UiPath Posts Weak Revenue, Joins SentinelOne, American Eagle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 0.1% on Thursday. UiPath reported quarterly earnings of nine cents per share, which beat the analyst consensus ...
Benzinga.com23d
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Intel Corporation INTC rose sharply in today's pre-market trading after the company announced a new chief executive officer. The company said its board of directors has appointed Lip-Bu ...